Impact of Perioperative Levosimendan Administration on Risk of Bleeding After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials
ConclusionThe analyzed parameters, including reoperations due to bleeding, postoperative chest drainage and the requirement for blood products, revealed that levosimendan did not increase postoperative bleeding risk. More studies with a larger sample size are needed to address a more reliable conclusion due to study limitations.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research
More News: Bleeding | Calcium | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Databases & Libraries | Heart | Potassium | Study